Estrella Immunopharma Inc

NASDAQ:ESLA 1:19:50 PM EDT

1.07

+0.02 (+1.57%)

Estrella Immunopharma Inc Stock, NASDAQ:ESLA

5858 Horton Street, Suite 370, Emeryville, California 94608

United States of America

Phone: +1.510.318.9098

Number of Employees:

http://www.estrellabio.com

Description

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.